Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cidara Therapeutics (CDTX) Change in Inventory: 2023-2024

Historic Change in Inventory for Cidara Therapeutics (CDTX) over the last 1 years, with Jun 2024 value amounting to -$7.3 million.

  • Cidara Therapeutics' Change in Inventory fell 404.40% to -$7.3 million in Q2 2024 from the same period last year, while for Jun 2024 it was -$2.4 million, marking a year-over-year change of. This contributed to the annual value of -$6.1 million for FY2024, which is 200.00% down from last year.
  • Latest data reveals that Cidara Therapeutics reported Change in Inventory of -$7.3 million as of Q2 2024, which was down 720.22% from $1.2 million recorded in Q1 2024.
  • Cidara Therapeutics' Change in Inventory's 5-year high stood at $3.2 million during Q4 2023, with a 5-year trough of -$7.3 million in Q2 2024.
  • Over the past 2 years, Cidara Therapeutics' median Change in Inventory value was $1.2 million (recorded in 2024), while the average stood at $0.
  • Data for Cidara Therapeutics' Change in Inventory shows a maximum YoY plummeted of 404.40% (in 2024) over the last 5 years.
  • Quarterly analysis of 2 years shows Cidara Therapeutics' Change in Inventory stood at $3.2 million in 2023, then crashed by 404.40% to -$7.3 million in 2024.
  • Its Change in Inventory stands at -$7.3 million for Q2 2024, versus $1.2 million for Q1 2024 and $3.2 million for Q4 2023.